As­traZeneca moves for­ward with a $360M API plant in Ire­land

As­traZeneca’s ap­pli­ca­tion for a $360 mil­lion man­u­fac­tur­ing site in a Dublin sub­urb is yet to be ac­cept­ed, but it is mak­ing progress.

The fa­cil­i­ty, which As­traZeneca first an­nounced in 2021, will be built at an Alex­ion site in the sub­urb of Blan­chard­stown and pro­duce APIs for small mol­e­cule ther­a­pies. Doc­u­ments sub­mit­ted to the Fin­gal Coun­ty Coun­cil’s Plan­ning and Strate­gic In­fra­struc­ture De­part­ment give more de­tails about the project.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN